| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
|
|
|
|||||||
|
|||||||||
American Journal of Clinical Nutrition, Vol 35, 73-82, Copyright © 1982 by The American Society for Clinical Nutrition, Inc
ORIGINAL RESEARCH COMMUNICATIONS |
CE Butterworth Jr, KD Hatch, H Gore, H Mueller and CL Krumdieck
Forty-seven young women with mild or moderate dysplasia of the uterine cervix (cervical intraepithelial neoplasia) diagnosed by cervical smears, received oral supplements of folic acid, 10 mg, or a placebo (ascorbic acid, 10 mg) daily for 3 months under double-blind conditions. All had used a combination-type oral contraceptive agent for at least 6 months and continued it while returning monthly for follow-up examinations. All smears and a biopsy obtained at the end of the trial period were classified by a single observer without knowledge of treatment status using an arbitrary scoring system (1 normal, 2 mild, 3 moderate, 4 severe, 5 carcinoma in situe). Mean biopsy scores from folate supplemented subjects were significantly better than in folate-unsupplemented subjects (2.28 versus 2.92, respectively; p less than 0.05). Final versus initial cytology scores were also significantly better in supplemented subjects (1.95 versus 2.32, respectively; p less than 0.05), unchanged in patients receiving the placebo (2.27 versus 2.30, respectively). Before treatment the mean red cell folate concentration was lower among oral contraceptive agent users than nonusers (189 versus 269 ng/ml, respectively; p less than 0.01) and even lower among users with dysplasia (161 versus 269 ng/ml, respectively; p less than 0.001). Morphological features of megaloblastosis were associated with dysplasia and also improved in folate supplemented subjects. These studies indicate that either a reversible, localized derangement in folate metabolism may sometimes be misdiagnosed as cervical dysplasia, or else such a derangement is an integral component of the dysplastic process that may be arrested or in some cases reversed by oral folic acid supplementation.
This article has been cited by other articles:
|
|
 |
|
  Y.-I. Kim Folic Acid Supplementation and Cancer Risk: Point Cancer Epidemiol. Biomarkers Prev., September 1, 2008; 17(9): 2220 - 2225. [Full Text] [PDF]
|
|
|
|
 |
|
 S. J Weinstein, R. Stolzenberg-Solomon, P. Pietinen, P. R Taylor, J. Virtamo, and D. Albanes Dietary factors of one-carbon metabolism and prostate cancer risk. Am. J. Clinical Nutrition, October 1, 2006; 84(4): 929 - 935. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 H. J. Powers Interaction among Folate, Riboflavin, Genotype, and Cancer, with Reference to Colorectal and Cervical Cancer J. Nutr., December 1, 2005; 135(12): 2960S - 2966S. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 A. S. Tsao, E. S. Kim, and W. K. Hong Chemoprevention of Cancer CA Cancer J Clin, May 1, 2004; 54(3): 150 - 180. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
R. G. Ziegler, S. J. Weinstein, and T. R. Fears Nutritional and Genetic Inefficiencies in One-Carbon Metabolism and Cervical Cancer Risk J. Nutr., August 1, 2002; 132(8): 2345S - 2349. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
P. S. Yan, C.-M. Chen, H. Shi, F. Rahmatpanah, S. H. Wei, and T. H.-M. Huang Applications of CpG Island Microarrays for High-Throughput Analysis of DNA Methylation J. Nutr., August 1, 2002; 132(8): 2430S - 2434. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
R. L. Sedjo, P. Inserra, M. Abrahamsen, R. B. Harris, D. J. Roe, S. Baldwin, and A. R. Giuliano Human Papillomavirus Persistence and Nutrients Involved in the Methylation Pathway among a Cohort of Young Women Cancer Epidemiol. Biomarkers Prev., April 1, 2002; 11(4): 353 - 359. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M. Follen, F. L. Meyskens Jr., E. N. Atkinson, and D. Schottenfeld Why Most Randomized Phase II Cervical Cancer Chemoprevention Trials are Uninformative: Lessons for the Future J Natl Cancer Inst, September 5, 2001; 93(17): 1293 - 1296. [Full Text] [PDF]
|
|
|
|
|
|
S. J. Weinstein, R. G. Ziegler, E. A. Frongillo Jr., N. Colman, H. E. Sauberlich, L. A. Brinton, R. F. Hamman, R. S. Levine, K. Mallin, P. D. Stolley, et al. Low Serum and Red Blood Cell Folate Are Moderately, but Nonsignificantly Associated with Increased Risk of Invasive Cervical Cancer in U.S. Women J. Nutr., July 1, 2001; 131(7): 2040 - 2048. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
L. A. Poirier, C. K. Wise, R. R. Delongchamp, and R. Sinha Blood Determinations of S-Adenosylmethionine, S-Adenosylhomocysteine, and Homocysteine: Correlations with Diet Cancer Epidemiol. Biomarkers Prev., June 1, 2001; 10(6): 649 - 655. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
A. J. Alberg, J. Selhub, K. V. Shah, R. P. Viscidi, G. W. Comstock, and K. J. Helzlsouer The Risk of Cervical Cancer in Relation to Serum Concentrations of Folate, Vitamin B12, and Homocysteine Cancer Epidemiol. Biomarkers Prev., July 1, 2000; 9(7): 761 - 764. [Abstract] [Full Text]
|
|
|
|
|
|
S.-W. Choi and J. B. Mason Folate and Carcinogenesis: An Integrated Scheme1-3 J. Nutr., January 1, 2000; 130(2): 129 - 132. [Abstract] [Full Text]
|
|
|
|
 |
|
 S. J. Duthie and A. Hawdon DNA instability (strand breakage, uracil misincorporation, and defective repair) is increased by folic acid depletion in human lymphocytes in vitro FASEB J, November 1, 1998; 12(14): 1491 - 1497. [Abstract] [Full Text]
|
|
|
|
 |
|
 M. J. Koury, D. J. Park, D. Martincic, D. W. Horne, V. Kravtsov, J. A. Whitlock, M. del Pilar Aguinaga, and P. Kopsombut Folate Deficiency Delays the Onset But Increases the Incidence of Leukemia in Friend Virus-Infected Mice Blood, November 15, 1997; 90(10): 4054 - 4061. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 R. Stolzenberg Possible Folate Deficiency With Postsurgical Infection Nutr Clin Pract, December 1, 1994; 9(6): 247 - 250. [Abstract] [PDF]
|
|
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
